Will Ozempic Become The Hottest New Workplace Benefit?

As employee benefits evolve, a new contender has emerged, generating significant buzz in corporate America—coverage for weight-loss medications like Ozempic, Wegovy, and Zepbound. These GLP-1 agonists, originally developed for type 2 diabetes treatment but now widely sought after for their weight loss effects, are reshaping how employers think about health benefits and how employees evaluate job opportunities. Ozempic, a brand name for semaglutide, has become especially popular for its effectiveness in managing blood sugar levels and promoting weight loss. With list prices hovering around $1,350 for a four-week supply of Wegovy, these GLP-1 agonists remain financially out of reach for...